期刊文献+

MMP-9、Cath-D阳性与胃癌生物学行为相关性 被引量:2

Relationship between postive MMP-9, Cath-D and biological behaviors in gastric carcinoma
暂未订购
导出
摘要 目的:探讨MMP-9和Cath-D阳性与胃癌生物学行为的关系。方法:采用免疫组化S-P法,检测MMP-9和Cath-D在128例原发性胃癌的阳性率。结果:128例胃癌组织中MMP-9和Cath-D阳性表达与胃癌生长方式、浸润深度、TNM分期、淋巴结转移密切相关(P<0.05);弥漫型胃癌MMP-9阳性率明显高于肠型胃癌(P<0.01);MMP-9和Cath-D阳性的胃癌患者五年生存率较阴性者低(P<0.05);两者在胃癌中阳性呈正相关,MMP-9(-)/Cath-D(-)组发生淋巴结转移和浆膜浸润的比率均明显低于MMP-9(+)/Cath-D(+)组、MMP-9(+)/cath-D(-)组和MMP-9(-)/Cath-D(+)组(P<0.05)。结论:MMP-9和(Sath-D与胃癌的生长、浸润、转移及预后均有密切关系,同时进行MMP-9和Cath-D免疫组化检测对于评估胃癌的预后有意义。 Purpose: To explore the relationship between positive MMP-9, Cath-D and biological behaviors in gastric carcinoma( GC). Methods: Positive MMP-9 and Cath-D were detected with S-P immunohistochemical method in 128 primary tumor specimens. Results: The positive rates of MMP-9 and Cath-D in 128 cases of human GC were correlated with growth pattern, depth of invasion, TNM categories, lymph nodes metastasis(P <0. 05). The positive rate of MMP-9 in diffuse-type carcinoma was much higher than that of intestinal-type. Five-year survival rate was significantly lower in MMP-9 or Cath-D positive GC than that in negative GC(P<0. 05) . Direct correlation was observed in GC between these two positives. The probability of lymph node metastases and serosal involvement in patients with MMP-9(- ) /Cath-D( - ) was lower than that in patients with MMP-9 ( + ) /Cath-D ( + ) or MMP-9 ( + ) /Cath-D ( - ) or MMP-9 ( - ) /Cath-D ( + ) ( P < 0. 05). Conclusions: The results demonstrate that MMP-9 and Cath-D are closely related to the growth, invasion metastasis and prognosis of GC. It is more significant for prognosis when MMP-9 and Cath-D are examined by using immunohistochemical staining at the same time.
出处 《中国癌症杂志》 CAS CSCD 2004年第2期131-134,共4页 China Oncology
关键词 胃癌 免疫组化 MMP-9 CATH-D 浸润转移 gastric carcinoma immunohistochemistry MMP-9 Cath-D invasion metastasis
  • 相关文献

参考文献11

  • 1Gaci Z, Bouin-Pineau MH, Gaci M, et al. Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup of nodenegative breast cancer patients with low histological grade tumors [J]. Int J Oncol,2001,18(4):793-800.
  • 2Ikeguchi M, Fukuda K, Oka S, et al. Clinicopathological significance of cathepsin D expression in gastric adeno carainoma [J]. Oncology,2001,61(1):71-78.
  • 3Chabowski A,Sulkowska, M,Sulkowskin M,et al. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer[J]. Folia Histochem Cytobiol,2001,39(2):153-154.
  • 4Chambers AF, Matrisian LM. Changing views of the role of matrix metalloprotinases in metastasis [J]. J Natl Cancer Inst,1997,89(17):1260-1270.
  • 5Liotta LA, Steeg PA, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation [J]. Cell,1991,64(2):327-336.
  • 6Volper OL, Hopwood D, Newman EL,et al. Combined analysis of p53 and TSP-1 in non-small-cell carcinoma [J]. Oncogene,1997,14(6):1495-1498.
  • 7Murray GI, Duncan ME, Arbuckle E, et al. Matrix metalloproteinases and their inhibitors in gastric cancer [J].Gut,1998,43(6):791-797.
  • 8Sier CF, Kubben FJ, Ganesh S, et al. Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survial of patients with gastric carcinoma [J]. Br J Cancer,1996,74(3):413-417.
  • 9Kiluk M, Skrzydlewski Z, Kiluk A, et al. Activity of cathepsin D in some neoplasms of gastrointestinal tract[J]. Pol Merkuriusz Lek, 1997,2(11):307-308.
  • 10Kantsaliev AL, Kozyreva EA, Kushlinskii NE, et al. Cathepsin D activity in gastric cancer[J]. Vopr Onkol,1994,40(1-3):40-46.

同被引文献27

  • 1LI Z, HOSOI Y, CAI K, et al. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation [ J ] . Biochem Biophys Res Commun, 2006, 341(2): 363-365.
  • 2FLAMANT L, NOTTE A, NINANE N, et alnti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia [ J ] . Mol Cancer, 2010, 13(9): 191-206.
  • 3VIRNA L, HOWARD D, MICHAEL B. Transcription factors as targets for cancer therapy: AP-1 a potential therapeutic target [ J ] . Curr Cancer Ther Rev, 2007, 3(1): 1-6.
  • 4KANG M, OH S, LEE H, et al. Metastatic function of BMP-2 in gastric cancer ceils: The role of PI3K/AKT, MAPK, the NF- K B pathway, and MMP-9 expression [ J ] . Exp Cell Res, 2011,317(12): 1746-1762.
  • 5WARMUTH M, DAMOISEAUX R, LIU Y, et al. SRC family kinases: potential targets for the treatment of human cancer and leukemia [ J ]. Curr Pharm Des, 2003, 9(25): 2043- 2059.
  • 6ALESHIN A, FINN R S. SRC: a century of science brought to the clinic [ J ] . Neoplasia, 2010, 12($): 599-607.
  • 7IRBY R B, YEATMAN T J. Role of Src expression and activation in human cancer [ J ] . Oncogene, 2000, 19(49): 5636-5642.
  • 8CHAMBERS A F, GROOM A C, MACDONALD I C. Dissemination and growth of cancer cells in metastatic sites [ J ] . Nat Rev Cancer, 2002, 2(8): 563-572.
  • 9SANSING H A, SARKESHIK A, YATES J R, et al. Integrin αβ 1, α v 13, β 613 effectors pl30Cas, Src and talin regulate carcinoma invasion and chemoresistance [ J ] . Biochem Biophys Res Commun, 2011, 406(2): 171-176.
  • 10Bertotti A, Bracco C, Girolami F, et al. Inhibition of Src impairs the growth of met-addicted gastric tumors [ J ] . Clin Cancer Res, 2010, 16(15): 3933-3943.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部